New Rochelle, NY, June 30, 2011--Mary Ann Liebert, Inc. is pleased to announce significant growth for many of its journals, according to the 2010 Impact Factors published by Thomson Reuters. More than half of the journals in the collection realized growth, with the majority achieving an increase of 10% and higher. This upward trend reflects Mary Ann Liebert Inc.'s high editorial standards for exceptional quality, supported by outstanding review boards and referees.
Mary Ann Liebert, President and CEO of Mary Ann Liebert, Inc. said: "We are extremely proud and appreciative of the achievements and contributions of our editors, editorial boards, and reviewers. We take pride in the value our publications bring to the scientific community, and celebrate their continued success."
Many of our bestselling journals demonstrated impressive growth, including:
- Antioxidants and Redox Signaling increased 8% to 8.209
- Human Gene Therapy increased 15% to 4.829
- Stem Cells and Development increased 16% to 4.791
- Thyroid increased 66% to 4.327
- Oligonucleotides (new title: Nucleic Acid Therapeutics) increased 19% to 2.986
- Journal of Interferon & Cytokine Research increased 58% to 2.576
In addition, two journals are included in the Thomson Reuters Journal Citation Reports for the first time with the following Impact Factors: Breastfeeding Medicine at 1.927 and Zebrafish at 1.886.
To preview the most cited articles in the collection, go to the individual journal web pages by visiting our website.
Mary Ann Liebert, Inc. is a privately held, fully integrated media company universally acknowledged for publishing authoritative peer-reviewed journals in the most promising areas of biomedical research, life sciences, medicine, surgery, and public health. Mary Ann Liebert, Inc. publications continue to make critical contributions in advancing research and facilitating collaboration throughout the world in academia, industry, and government, and are also highly respected resources for legislators, policy makers, and educators. A complete list of the firm's 60 journals, books, and newsmagazines is available at our website.